Your session is about to expire
← Back to Search
ALTB-268 for Healthy Volunteers
Study Summary
This trial will test a drug's safety, how it works in the body, and how it's absorbed and used in healthy people.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- If the investigator thinks that you have a medical condition that could be too risky for you to participate in the study, you will be excluded.You cannot have taken any experimental medication or device within the past month or within five times the medication's half-life before starting the study drug.You have a history of severe allergic reactions to drugs or food, which required treatment with medication like steroids or epinephrine.
- Group 1: ALTB-268
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could I potentially enroll in this clinical investigation?
"Eligible participants must be in good health and between the ages of 18-55. For this study, 64 people are needed to complete it."
Are elderly citizens being considered for this experimental treatment?
"This trial requires that participants are aged between 18 to 55 years. For minors, there are 51 clinical trials available and for seniors over 65, 360 studies have been created."
Is this research endeavor actively enlisting participants?
"According to the details provided on clinicaltrials.gov, this trial is actively seeking participants. The study was first uploaded onto the database on January 17th 2023 and its most recent update happened on February 9th of the same year."
What implications could ALTB-268 have on human health?
"Data concerning the safety of ALTB-268 is still limited, hence why it received a score of 1. This reflects that this medical trial currently in Phase 1 and lacks extensive evidence on efficacy or safety."
How many people is the maximum capacity for this investigation?
"Indeed, the information posted on clinicaltrials.gov makes it evident that this medical experiment is currently seeking participants. It was initially announced on January 17th 2023 and most recently updated February 9th of the same year. 64 patients are required from a single location for enrollment."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger